Mechanisms of oncogenic chromosomal translocations

Annals of the New York Academy of Sciences

Volumn 1310, Issue 1, 2014, Pages 89-97

  Byrne, Michael ^a   Wray, Justin ^a   Reinert, Brian ^a   Wu, Yuehan ^a   Nickoloff, Jac ^b   Lee, Suk Hee ^c   Hromas, Robert ^a   Williamson, Elizabeth ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosomal translocation; DNA end joining repair; DNA repair; Oncogenesis

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ETOPOSIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OLAPARIB; RAG1 PROTEIN; RAG2 PROTEIN; RUCAPARIB;

ARTICLE; CANCER CHEMOTHERAPY; CHROMOSOME TRANSLOCATION; DNA END JOINING REPAIR; DNA REPAIR; DNA STRUCTURE; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVITY; HUMAN; IONIZING RADIATION; NONHUMAN; SIGNAL TRANSDUCTION;

CHROMOSOMAL TRANSLOCATION; DNA END-JOINING REPAIR; DNA REPAIR; ONCOGENESIS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DEOXYRIBONUCLEASES; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; DNA REPAIR; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; RECEPTORS, IMMUNOLOGIC; TRANSLOCATION, GENETIC;

EID: 84896277262     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12370     Document Type: Article

References (86)

1. Sax, K. 1938. Chromosome aberrations induced by X-rays. Genetics. 23: 494-516.
2. Chandra, H.S. et al. 2011. Philadelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome. Cancer Genet. 204: 171-179.
3. Aplan, P.D. 2006. Causes of oncogenic chromosomal translocation. Trends. Genet. 22: 46-55.
4. Nickoloff, J.A. et al. 2008. Mechanisms of leukemia translocations. Curr. Opin. Hematol. 15: 338-345.
5. Das, K. & P. Tan. 2013. Molecular cytogenetics: recent developments and applications in cancer. Clin. Genet. 84: 315-325.
6. Wang, J.H. 2012. Mechanisms and impacts of chromosomal translocations in cancers. Front. Med. 6: 263-274.
7. Pillai, R.N. & S.S. Ramalingam. 2012. The biology and clinical features of non-small cell lung cancers with EML4-ALK translocation. Curr. Oncol. Rep. 14: 105-110.
8. Chesi, M. & P.L. Bergsagel. 2013. Molecular pathogenesis of multiple myeloma: basic and clinical updates. Int. J. Hematol. 97: 313-323.
9. Salas, C., P. Pérez-Vera & S. Frías. 2011. Genetic abnormalities in leukemia secondary to treatment in patients with Hodgkin's disease. Rev. Invest. Clin. 63: 53-63.
10. Harrison, C.J. 2013. Targeting signaling pathways in acute lymphoblastic leukemia: new insights. Hematology Am. Soc. Hematol. Educ. Program 2013: 118-125.
11. Leone, G. et al. 2001. Therapy related leukemias: susceptibility, prevention and treatment. Leuk. Lymphoma. 41: 255-276.
12. Hromas, R. et al. 2000. A novel syndrome of radiation-associated acute myeloid leukemia involving AML1 gene translocations. Blood 95: 4011-4013.
13. Weinstock, D.M., B. Elliott & M. Jasin. 2006. A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair. Blood 107: 777-780.
14. Gellert, M. 2002. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71: 101-132.
15. Fugmann, S.D. et al. 2000. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18: 495-527.
16. Muramatsu, M. et al. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
17. Revy, P. et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
18. Marculescu, R. et al. 2002. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites. J. Exp. Med. 195: 85-98.
19. Arnal, S.M. et al. 2010. Non-consensus heptamer sequences destabilize the RAG post-cleavage complex, making ends available to alternative DNA repair pathways. Nucleic. Acids. Res. 38: 2944-2954.
20. Alt, F.W. et al. 2013. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 152: 417-429.
21. Zhang, Y. et al. 2012. Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 148: 908-921.
22. Posey, J.E. et al. 2006. Target DNA structure plays a critical role in RAG transposition. PLoS Biol. 4: e350.
23. Raghavan, S.C. et al. 2007. The structure-specific nicking of small heteroduplexes by the RAG complex: implications for lymphoid chromosomal translocations. D.N.A. Repair (Amst.). 6: 751-759.
24. Raghavan, S.C. et al. 2005. Evidence for a triplex DNA conformation at the bcl-2 major breakpoint region of the t(14;18) translocation. J. Biol. Chem. 280: 22749-22760.
25. Raghavan, S.C. et al. 2004. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature. 428: 88-93.
26. Nambiar, M. et al. 2011. Formation of a G-quadruplex at the BCL2 major breakpoint region of the t(14;18) translocation in follicular lymphoma. Nucleic. Acids. Res. 39: 936-948.
27. Wang, G. et al. 2008. DNA structure-induced genomic instability in vivo. J. Natl. Cancer Inst. 100: 1815-1817.
28. Howarth, K.D. et al. 2011. Large duplications at reciprocal translocation breakpoints that might be the counterpart of large deletions and could arise from stalled replication bubbles. Genome. Res. 21: 525-534.
29. Errico, A. & V. Costanzo. 2012. Mechanisms of replication fork protection: a safeguard for genome stability. Crit. Rev. Biochem. Mol. Biol. 47: 222-235.
30. Robbiani, D.F. et al. 2009. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell. 36: 631-641.
31. Robbiani, D.F. et al. 2008. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell. 135: 1028-1038.
32. Koduru, S. et al. 2012. Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma. Blood 119: 2302-2309.
33. Okazaki, I.M., A. Kotani & T. Honjo. 2007. Role of AID in tumorigenesis. Adv. Immunol. 94: 245-273.
34. Lin, C. et al. 2009. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell. 139: 1069-1083.
35. Mani, R.S. et al. 2009. Induced chromosomal proximity and gene fusions in prostate cancer. Science 326: 1230.
36. Casey, O.M. et al. 2012. TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation. PLoS One 7: e41668.
37. Kolomietz, E. et al. 2002. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes. Chromosomes. Cancer. 35: 97-112.
38. Elliott, B., C. Richardson & M. Jasin. 2005. Chromosomal translocation mechanisms at intronic alu elements in mammalian cells. Mol. Cell. 17: 885-894.
39. Hess, J.L. 2004. MLL: a histone methyltransferase disrupted in leukemia. Trends. Mol. Med. 10: 500-507.
40. Jeffs, A.R., E. Wells & C.M. Morris. 2001. Nonrandom distribution of interspersed repeat elements in the BCR and ABL1 genes and its relation to breakpoint cluster regions. Genes. Chromosomes. Cancer 32: 144-154.
41. Kurahashi, H. et al. 2006. Palindrome-mediated chromosomal translocations in humans. DNA Repair (Amst.) 5: 1136-1145.
42. Kurahashi, H. et al. 2000. Regions of genomic instability on 22q11 and 11q23 as the etiology for the recurrent constitutional t(11;22). Hum. Mol. Genet. 9: 1665-1670.
43. Kurahashi, H. et al. 2004. Cruciform DNA structure underlies the etiology for palindrome-mediated human chromosomal translocations. J. Biol. Chem. 279: 35377-35383.
44. Coté, A.G. & S.M. Lewis. 2008. Mus81-dependent double-strand DNA breaks at in vivo-generated cruciform structures in S. cerevisiae. Mol. Cell. 31: 800-812.
45. Allen, C. et al. 2011. More forks on the road to replication stress recovery. J. Mol. Cell. Biol. 3: 4-12.
46. Fenech, M. et al. 2011. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis. 26: 125-132.
47. Bower, J.J. et al. 2010. Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling. Oncogene. 29: 4787-4799.
48. Kaufmann, W.K. 2006. Dangerous entanglements. Trends. Mol. Med. 12: 235-237.
49. Povirk, L.F. 2006. Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks. DNA Repair (Amst.) 5: 1199-1212.
50. Shaheen, M. et al. 2011. Synthetic lethality: exploiting the addiction of cancer to DNA repair. Blood 117: 6074-6082.
51. Thompson, L.H. 2012. Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Mutat. Res. 751: 158-246.
52. Mladenov, E. & G. Iliakis. 2011. Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways. Mutat. Res. 711: 61-72.
53. Brandsma, I. & D.C. Gent. 2012. Pathway choice in DNA double strand break repair: observations of a balancing act. Genome. Integr. 3: 9.
54. Chapman, J.R., M.R. Taylor & S.J. Boulton. 2012. Playing the end game: DNA double-strand break repair pathway choice. Mol. Cell. 47: 497-510.
55. Rowley, J.D. 1999. The role of chromosome translocations in leukemogenesis. Semin. Hematol. 36: 59-72.
56. Zhang, Y. & J.D. Rowley. 2006. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair. (Amst.) 5: 1282-1297.
57. Kelly, L.M. & D.G. Gilliland. 2002. Genetics of myeloid leukemias. Annu. Rev. Genomics. Hum. Genet. 3: 179-198.
58. Mattarucchi, E. et al. 2008. Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia. Genes. Chromosomes. Cancer 47: 625-632.
59. Shahar, O.D. et al. 2012. Live imaging of induced and controlled DNA double-strand break formation reveals extremely low repair by homologous recombination in human cells. Oncogene. 31: 3495-3504.
60. Boboila, C., F.W. Alt & B. Schwer. 2012. Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks. Adv. Immunol. 116: 1-49.
61. McVey, M. & S.E. Lee. 2008. MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends. Genet. 24: 529-538.
62. Cheng, Q. et al. 2011. Ku counteracts mobilization of PARP1 and MRN in chromatin damaged with DNA double-strand breaks. Nucleic. Acids. Res. 39: 9605-9619.
63. Wang, M. et al. 2006. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic. Acids. Res. 34: 6170-6182.
64. Mimitou, E.P., & L.S. Symington. 2009. DNA end resection: many nucleases make light work. DNA Repair. (Amst.) 8: 983-995.
65. Ma, Y., K. Schwarz & M.R. Lieber. 2005. The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps. DNA Repair (Amst.) 4: 845-851.
66. Beck, B.D. et al. 2011. Biochemical characterization of metnase's endonuclease activity and its role in NHEJ repair. Biochemistry 50: 4360-4370.
67. Symington, L.S. & J. Gautier. 2011. Double-strand break end resection and repair pathway choice. Annu. Rev. Genet. 45: 247-271.
68. Bothmer, A. et al. 2013. Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. J. Exp. Med. 210: 115-123.
69. Simsek, D. & M. Jasin. 2010. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat. Struct. Mol. Biol. 17: 410-416.
70. Wray, J. et al. 2010. The transposase domain protein Metnase/SETMAR suppresses chromosomal translocations. Cancer. Genet. Cytogenet. 200: 184-190.
71. Weinstock, D.M., E. Brunet & M. Jasin. 2007. Formation of NHEJ-derived reciprocal chromosomal translocations does not require Ku70. Nat. Cell. Biol. 9: 978-981.
72. Guirouilh-Barbat, J., S. Huck & B.S. Lopez. 2008. S-phase progression stimulates both the mutagenic KU-independent pathway and mutagenic processing of KU-dependent intermediates, for nonhomologous end joining. Oncogene. 27: 1726-1736.
73. Simsek, D. et al. 2011. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS. Genet. 7: e1002080.
74. Zhang, Y. & M. Jasin. 2011. An essential role for CtIP in chromosomal translocation formation through an alternative end-joining pathway. Nat. Struct. Mol. Biol. 18: 80-84.
75. Lee-Theilen, M. et al. 2011. CtIP promotes microhomology-mediated alternative end joining during class-switch recombination. Nat. Struct. Mol. Biol. 18: 75-79.
76. Mao, Z. et al. 2011. SIRT6 promotes DNA repair under stress by activating PARP1. Science 332: 1443-1446.
77. Gibson, B.A. & W.L. Kraus. 2012. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat. Rev. Mol. Cell. Biol. 13: 411-424.
78. Audebert, M., B. Salles & P. Calsou. 2004. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J. Biol. Chem. 279: 55117-55126.
79. Mansour, W.Y., T. Rhein & J. Dahm-Daphi. 2010. The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies. Nucleic. Acids. Res. 38: 6065-6077.
80. Rahal, E.A. et al. 2010. ATM regulates Mre11-dependent DNA end-degradation and microhomology-mediated end joining. Cell. Cycle. 9: 2866-2877.
81. Della-Maria, J. et al. 2011. Human Mre11/human Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act together in an alternative nonhomologous end joining pathway. J. Biol. Chem. 286: 33845-33853.
82. Penning, T.D. 2010. Small-molecule PARP modulators: current status and future therapeutic potential. Curr. Opin. Drug. Discov. Devel. 13: 577-586.
83. Wray, J. et al. 2013. PARP1 is required for chromosomal translocations. Blood 121: 4359-4365.
84. Misteli, T. & E. Soutoglou. 2009. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat. Rev. Mol. Cell. Biol. 10: 243-254.
85. Brown, J.R. et al. 2005. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J. Clin. Oncol. 23: 2208-2214.
86. Leiper, A.D. 1995. Late effects of total body irradiation. Arch. Dis. Child. 72: 382-385.